Wenbo Qi Dayong Xi Yuping Bai Le Liu Yanling Ma Zhenyu Yin Hao Chen
10.3389/fphar.2023.1026135
Front Pharmacol
2023 Jan 12;14:1026135.
kras nsclc tp53 anlotinib camrelizumab case report chemotherapy-free
CC BY
https://pubmed.ncbi.nlm.nih.gov/36713848/
Case Reports
PMC9878280
36713848
Case Report: Chemotherapy-free treatment with camrelizumab and anlotinib for elderly patients with KRAS and TP53 mutated advanced lung cancer
2023